Dr Reddys Laboratories reports over two fold rise in Q2 net profit

30 Oct 2012 Evaluate

Dr Reddys Laboratories has reported results for second quarter ended September 30, 2012.

On standalone basis, the company has posted a rise of 162.11% in its net profit at Rs 363.03 crore for the quarter ended September 30, 2012 as compared to Rs 138.50 crore for the same quarter in the previous year.  Total income has increased by 36.89% at Rs 2272.44 crore for quarter under review as compared to Rs 1660.03 crore for the quarter ended September 30, 2011.

On Consolidated basis, the company has posted a rise of 32.37% in its net profit at Rs 407.44 crore for the quarter ended September 30, 2012 as compared to Rs 307.80 crore for the same quarter in the previous year.  Total income has increased by 27.57% at Rs 2920.49 crore for quarter under review as compared to Rs 2289.31 crore for the quarter ended September 30, 2011.

Dr. Reddys Lab Share Price

1272.70 -2.35 (-0.18%)
08-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 920.90
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×